SNPX: Synaptogenix, Inc. Stock

by  •  • Comments Off on SNPX: Synaptogenix, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 3.03
Enterprise Value ($M) -13.71
Book Value ($M) 6.78
Book Value / Share 4.88
Price / Book 0.45
NCAV ($M) 6.76
NCAV / Share 4.87
Price / NCAV 0.45

Profitability (mra)
Return on Invested Capital (ROIC) -1.88
Return on Assets (ROA) -0.43
Return on Equity (ROE) -0.56

Liquidity (mrq)
Quick Ratio 17.47
Current Ratio 17.47

Balance Sheet (mrq) ($M)
Current Assets 17.72
Assets 17.73
Liabilities 10.96
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -6.81
Net Income -12.77
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -4.88
Cash from Investing -1.00
Cash from Financing -5.12

(click for more detail)
Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-27 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTI
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-17 811 2,128 38.11
2025-04-16 904 2,361 38.29
2025-04-15 2,546 7,356 34.61
2025-04-14 1,242 3,685 33.70

(click for more detail)

Similar Companies
SLS – SELLAS Life Sciences Group, Inc. SNDL – SNDL Inc.
SNGX – Soligenix, Inc. SNSE – Sensei Biotherapeutics, Inc.
SNTI – Senti Biosciences, Inc.


Financial data and stock pages provided by
Fintel.io